Novel insights into Chk1 regulation by phosphorylation.

Checkpoint kinase 1 (Chk1) is a conserved protein kinase central to the cell-cycle checkpoint during DNA damage response (DDR). Until recently, ATR, a protein kinase activated in response to DNA damage or stalled replication, has been considered as the sole regulator of Chk1. Recent progress, however, has led to the identification of additional protein kinases involved in Chk1 phosphorylation, affecting the subcellular localization and binding partners of Chk1. In fact, spatio-temporal regulation of Chk1 is of critical importance not only in the DDR but also in normal cell-cycle progression. In due course, many potent inhibitors targeted to Chk1 have been developed as anticancer agents and some of these inhibitors are currently in clinical trials. In this review, we summarize the current knowledge of Chk1 regulation by phosphorylation.

[1]  C. McGowan,et al.  Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  M. O'Connell,et al.  Regulatory motifs in Chk1 , 2013, Cell cycle.

[3]  H. Zentgraf,et al.  Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1 , 2009, The Journal of cell biology.

[4]  K. Helin,et al.  NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint , 2009, Nature Cell Biology.

[5]  H. Piwnica-Worms,et al.  DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. , 2009, Cancer research.

[6]  S. Jackson,et al.  Rapid PIKK-Dependent Release of Chk1 from Chromatin Promotes the DNA-Damage Checkpoint Response , 2006, Current Biology.

[7]  Benjamin J. Raphael,et al.  De novo discovery of mutated driver pathways in cancer , 2011 .

[8]  S. Elledge,et al.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. , 2000, Genes & development.

[9]  Junjie Chen,et al.  Claspin, a regulator of Chk1 in DNA replication stress pathway. , 2004, DNA repair.

[10]  Jiri Bartek,et al.  Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks , 2006, The Journal of cell biology.

[11]  E. Appella,et al.  Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase , 2001, Nature.

[12]  K. Cimprich,et al.  ATR: an essential regulator of genome integrity , 2008, Nature Reviews Molecular Cell Biology.

[13]  N. Rhind,et al.  Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways. , 2000, Journal of cell science.

[14]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[15]  D. Gillespie,et al.  Chk1 regulates the density of active replication origins during the vertebrate S phase , 2007, The EMBO journal.

[16]  T. Helleday,et al.  Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control , 2008, Proceedings of the National Academy of Sciences.

[17]  T. Hunter,et al.  The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress. , 2009, Molecular cell.

[18]  A. Kumagai,et al.  Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. , 2000, Molecular cell.

[19]  Michael B Yaffe,et al.  MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. , 2005, Molecular cell.

[20]  P. Clarke,et al.  DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system. , 2005, The Biochemical journal.

[21]  Makoto Nakanishi,et al.  Chk1 Is a Histone H3 Threonine 11 Kinase that Regulates DNA Damage-Induced Transcriptional Repression , 2008, Cell.

[22]  Xiujing Feng,et al.  Coupling Cellular Localization and Function of Checkpoint Kinase 1 (Chk1) in Checkpoints and Cell Viability* , 2012, The Journal of Biological Chemistry.

[23]  A. Eastman,et al.  The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design. , 2013, British journal of clinical pharmacology.

[24]  D. Gillespie,et al.  Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity , 2009, Oncogene.

[25]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[26]  R. Abraham,et al.  Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. , 2005, Molecular cell.

[27]  G. Wahl,et al.  MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.

[28]  F. Quelle,et al.  DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. , 2001, Blood.

[29]  M. Garrett,et al.  CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin? , 2007, Nature Reviews Cancer.

[30]  N. Walworth,et al.  Importance of a C-Terminal Conserved Region of Chk1 for Checkpoint Function , 2008, PloS one.

[31]  L. Donehower,et al.  PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. , 2005, Genes & development.

[32]  J. Bartek,et al.  Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin‐dependent kinase 1 (Cdk1) , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[33]  Yingming Zhao,et al.  TAO kinases mediate activation of p38 in response to DNA damage , 2007, The EMBO journal.

[34]  M. O'Connell,et al.  Regulation of Chk1 by its C-terminal domain. , 2008, Molecular biology of the cell.

[35]  Y. A. Minamishima,et al.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. , 2000, Genes & development.

[36]  A. Carr,et al.  Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice , 2000, Current Biology.

[37]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[38]  K. Cimprich,et al.  Causes and consequences of replication stress , 2013, Nature Cell Biology.

[39]  M. Inagaki,et al.  Novel Positive Feedback Loop between Cdk1 and Chk1 in the Nucleus during G2/M Transition* , 2009, The Journal of Biological Chemistry.

[40]  L. Zou,et al.  ATR: a master conductor of cellular responses to DNA replication stress. , 2011, Trends in biochemical sciences.

[41]  N. Mailand,et al.  Centrosome-associated Chk1 prevents premature activation of cyclin-B–Cdk1 kinase , 2004, Nature Cell Biology.

[42]  Y. Yatabe,et al.  P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation , 2012, Molecular biology of the cell.

[43]  D. Gillespie,et al.  Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage , 2012, Oncogene.

[44]  J. Bartek,et al.  Inhibition of Human Chk1 Causes Increased Initiation of DNA Replication, Phosphorylation of ATR Targets, and DNA Breakage , 2005, Molecular and Cellular Biology.

[45]  Bernard Ducommun,et al.  CDC25 phosphatases in cancer cells: key players? Good targets? , 2007, Nature Reviews Cancer.

[46]  L. Carrassa,et al.  Unleashing Chk1 in cancer therapy , 2011, Cell cycle.

[47]  J. Bartek,et al.  Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage , 2003, Nature Cell Biology.

[48]  Soo-Mi Kim,et al.  Claspin and the Activated Form of ATR-ATRIP Collaborate in the Activation of Chk1* , 2004, Journal of Biological Chemistry.

[49]  N. Hay,et al.  Inhibition of Chk1 by Activated PKB/Akt , 2004, Cell cycle.

[50]  M. Inagaki,et al.  14‐3‐3γ mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage , 2010, The EMBO journal.

[51]  D. Baltimore,et al.  ATR disruption leads to chromosomal fragmentation and early embryonic lethality. , 2000, Genes & development.

[52]  D. Nimbalkar,et al.  Phosphoinositide 3-kinase signaling overrides a G2 phase arrest checkpoint and promotes aberrant cell cycling and death of hematopoietic cells after DNA damage , 2008, Cell cycle.

[53]  M. Yaffe,et al.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. , 2009, Current opinion in cell biology.

[54]  H. Piwnica-Worms,et al.  ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1 , 2001, Molecular and Cellular Biology.

[55]  H. Niida,et al.  Specific Role of Chk1 Phosphorylations in Cell Survival and Checkpoint Activation , 2007, Molecular and Cellular Biology.

[56]  Jun Qin,et al.  SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. , 2003, Genes & development.

[57]  D. Ginsberg,et al.  p53 and E2f: partners in life and death , 2009, Nature Reviews Cancer.

[58]  T. Pandita,et al.  Lack of PTEN sequesters CHK1 and initiates genetic instability. , 2005, Cancer cell.

[59]  H. Piwnica-Worms,et al.  Cdc25A Regulation: To Destroy or Not to Destroy, Is That the Only Question? , 2003, Cell cycle.

[60]  N. Walworth,et al.  Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest , 2002, Journal of Cell Science.

[61]  D. Gillespie,et al.  Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency. , 2011, Biochemical and biophysical research communications.

[62]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[63]  S. Carr,et al.  DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. , 2010, Molecular cell.

[64]  H. Piwnica-Worms,et al.  Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. , 2011, Trends in molecular medicine.

[65]  Y. Sánchez,et al.  Regulation of Chk1 Includes Chromatin Association and 14-3-3 Binding following Phosphorylation on Ser-345* , 2003, Journal of Biological Chemistry.

[66]  Yun Dai,et al.  New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network , 2010, Clinical Cancer Research.

[67]  H. Piwnica-Worms,et al.  Phosphorylation of Chk1 by ATR Is Antagonized by a Chk1-Regulated Protein Phosphatase 2A Circuit , 2006, Molecular and Cellular Biology.

[68]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[69]  A. Behrens,et al.  ATM signalling and cancer , 2014, Oncogene.

[70]  H. Piwnica-Worms,et al.  Casein Kinase 1 Functions as both Penultimate and Ultimate Kinase in Regulating Cdc25A Destruction , 2010, Oncogene.

[71]  N. Hay,et al.  Akt Activation Emulates Chk1 Inhibition and Bcl2 Overexpression and Abrogates G2 Cell Cycle Checkpoint by Inhibiting BRCA1 Foci* , 2010, The Journal of Biological Chemistry.

[72]  M. Nakanishi,et al.  Nuclear Chk1 prevents premature mitotic entry , 2011, Journal of Cell Science.

[73]  H. Piwnica-Worms,et al.  CRL4CDT2 Targets CHK1 for PCNA-Independent Destruction , 2012, Molecular and Cellular Biology.

[74]  M. Yaffe,et al.  14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. , 2009, DNA repair.

[75]  N. Sagata,et al.  Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation. , 2004, Molecular biology of the cell.

[76]  H. Piwnica-Worms,et al.  Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding , 2003, Molecular and Cellular Biology.

[77]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[78]  Youwei Zhang,et al.  Roles of Chk1 in cell biology and cancer therapy , 2014, International journal of cancer.

[79]  M. Bartucci,et al.  Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy. , 2013, Cancer treatment reviews.

[80]  Y. Shiloh,et al.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more , 2013, Nature Reviews Molecular Cell Biology.

[81]  D. Gillespie,et al.  Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2 , 2010, The Journal of cell biology.

[82]  J. Pines,et al.  Active cyclin B1–Cdk1 first appears on centrosomes in prophase , 2003, Nature Cell Biology.

[83]  Michael B Yaffe,et al.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. , 2007, Cancer cell.

[84]  L. Busino,et al.  Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis , 2004, Oncogene.

[85]  M. Inagaki,et al.  Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti‐cancer therapy? , 2012, Cancer science.

[86]  M. Inagaki,et al.  Chk1 phosphorylation at Ser286 and Ser301 occurs with both stalled DNA replication and damage checkpoint stimulation. , 2008, Biochemical and biophysical research communications.

[87]  S. Elledge,et al.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.

[88]  D. Stokoe,et al.  A Role for PI 3-Kinase and PKB Activity in the G2/M Phase of the Cell Cycle , 2002, Current Biology.